Medical uses of in situ formed gels

Details Medical uses of in situ formed gels Medical uses of in situ formed gels

1993-12-28

1996-12-24

Azpuru, Carlos

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

424 7802, 424 7817, 424 7818, 424 7826, 424 7837, 424430, 424436, 424486, 424488, 424497, 5147727, 514779, 514912, 514913, 514914, 514944, 514966, 514967, 523122, 623 5, A61K 3177, A61K 31725, A61K 3173, A61K 214

Patent

active

055871755

ABSTRACT:
Balanced pH, hyperosmotic, hypoosmotic, or isoosmotic gels are ideal vehicles for drug delivery. They are especially suited for topical body cavity or injection application of drugs or diagnostic agents; for drug or diagnostic agent delivery to the eye of a mammal; as protective corneal shields; or as ablatable corneal masks useful in laser reprofiling of the cornea. The compositions without the addition of a drug or diagnostic agent are useful as medical devices, for instance, in separating surgically or otherwise injured tissue as a means of preventing adhesions.

REFERENCES:
patent: 3590125 (1969-10-01), Hymes
patent: 3640741 (1972-02-01), Etes
patent: 3867521 (1972-02-01), Miskel
patent: 4100271 (1976-02-01), Krezanoski
patent: 4188373 (1977-11-01), Krezanoski
patent: 4439196 (1984-03-01), Higuchi
patent: 4474751 (1984-10-01), Haslam et al.
patent: 4474752 (1984-10-01), Haslam
patent: 4475753 (1984-10-01), Haslam et al.
patent: 4478822 (1984-10-01), Haslam
patent: 4511563 (1985-04-01), Schmolka
patent: 4540407 (1985-09-01), Dunn
patent: 4570626 (1986-02-01), Norris et al.
patent: 4767619 (1988-08-01), Murray
patent: 4795642 (1989-01-01), Cohen et al.
patent: 4856513 (1989-08-01), Muller
patent: 4861580 (1989-08-01), Janoff et al.
patent: 4861760 (1989-08-01), Mazuel et al.
patent: 4879109 (1989-11-01), Hunter
patent: 4883660 (1989-11-01), Blackman et al.
patent: 4895724 (1990-01-01), Cardinal et al.
patent: 4911926 (1990-03-01), Henry et al.
patent: 4913903 (1990-04-01), Sudmann et al.
patent: 4948575 (1990-08-01), Cole et al.
patent: 5068225 (1990-08-01), Pennell et al.
patent: 5071644 (1991-12-01), Viegas et al.
patent: 5080893 (1992-01-01), Goldberg et al.
patent: 5214093 (1993-05-01), Nell et al.
patent: 5219895 (1993-06-01), Kelman et al.
patent: 5279611 (1994-01-01), McDonnell et al.
Kim, et al., "Pluronic.RTM. Polyol: A Potential Alloplastic Keratorefractive Material"; Journal of Cataract Refractive Surgery, vol. 14, May 1988, pp. 312-316.
Bodmeier et al. (1989), J. Pharmaceutical Sciences, vol. 78(11), pp. 964-967.
Amies, C. R. (1959), J. Pathology & Bacteriology, vol. 77, pp. 435-442.
Pfister et al. (1986), J. Controlled Release, vol. 3, pp. 229-233.
Poland et al. (1988), J. Cataract Refractive Surgery, vol. 14, pp. 489-491.
Trokel et al. (1983), Am. J. Ophthalmol., vol. 96, pp. 710-715.
Marshall et al. (1985), Ophthalmology, vol. 92, pp. 749-758.
Cotliar et al. (1985), Ophthalmology, vol. 92, pp. 206-208.
Puliafito, C. A. (1985), Ophthalmology, vol. 92, pp. 741-748.
Kruegar and Trokel (1985), Arch. Opthalmol., vol. 103, pp. 1741-1742.
Hanna et al. (1989), Arch. Ophthalmol., vol. 107, pp. 895-901.
Taylor et al. (1989), Ophthalmology, vol. 96, pp. 654-664.
Hanna et al. (1988), Arch. of Ophthalmology, vol. 106, pp. 245-250.
Search Results Dialog, Dec. 23, 1993.
Search Results Dialog, Dec. 29, 1993.
Shofner et al. (1989), Ophthalmology Clinics of North America, vol. 2(1), pp. 15-23.
Fantes et al. (1990), Arch. Ophthalmol., vol. 108, pp. 665-675.

Affiliated with

Also associated with

Rating

Medical uses of in situ formed gels does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medical uses of in situ formed gels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical uses of in situ formed gels will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1177191